Related Experiment Video
Updated: May 9, 2026

13:36
Generation of Monocyte-Derived Dendritic Cells with Differing Sialylated Phenotypes
Published on: October 20, 2023
Tunable heparan sulfate mimetics for modulating chemokine activity
Gloria J Sheng1, Young In Oh, Shuh-Kuen Chang
1Division of Chemistry and Chemical Engineering, California Institute of Technology and Howard Hughes Medical Institute, 1200 East California Boulevard, Pasadena, California 91125, USA.
Journal of the American Chemical Society
|July 25, 2013
Summary
This study presents a new method to create heparan sulfate (HS) mimetics. These compounds can block immune cell migration by targeting specific chemokines, offering a potential therapeutic strategy.
Area of Science:
- Glycoscience
- Immunology
- Medicinal Chemistry
Background:
- Heparan sulfate (HS) glycosaminoglycans are crucial in biological processes, regulating protein interactions, including those with chemokines involved in immune cell migration.
- Understanding HS-protein interactions is key to modulating immune responses and related diseases.
Purpose of the Study:
- To develop an efficient synthesis for defined HS glycomimetics that mimic the structure and function of natural HS.
- To investigate the potential of these synthetic HS mimetics as modulators of chemokine activity, particularly in inflammation.
Main Methods:
- A divergent synthesis strategy using a core disaccharide precursor to generate various differentially sulfated glycopolymers.
- Testing the biological activity of synthesized HS mimetics, focusing on their ability to antagonize chemokine function and their specificity.
Main Results:
- Successfully synthesized a library of defined HS glycomimetics with varying sulfation patterns.
- A specific trisulfated HS mimetic demonstrated potent antagonism of the proinflammatory chemokine RANTES, comparable to heparin.
- This trisulfated mimetic selectively inhibited RANTES chemotaxis without affecting blood coagulation serine proteases.
Conclusions:
- The developed synthetic approach provides a versatile platform for creating HS-based glycomimetics.
- These defined HS mimetics can effectively modulate chemokine activity, offering a targeted approach to controlling immune cell migration.
- The findings highlight the potential of HS mimetics in therapeutic strategies for inflammatory diseases and for further dissecting HS-related biological functions.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

